Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Biotech ETF (BBH)

Delayed Data
As of Mar 24
 +0.66 / +0.56%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVISä US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Time to Buy Biotech ETFs?
Mar 13 / Zacks.com - Paid Partner Content


1 month-0.72% 3 years+8.70%
3 months+7.73% 5 years+22.48%
1 year+15.64% Since inception+25.96%
Data through 03/25/2017

Quote Details

Previous close$117.14
Open day’s range117.21 – 118.16
Net asset value (NAV)117.70 (03/24/2017)
Daily volume16,926
Average volume (3 months)68,194
Data as of 3:59pm ET, 03/24/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.48%+16.84%
Expense Gross exp ratio0.40%1.33%
Risk 5 year sharpe ratio1.091.11
Net assets$709.1M$3.0B
Average market cap$36.9B$30.5B
Average P/E20.122.3
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen13.13%
CELG Celgene10.87%
GILD Gilead Sciences9.88%
AGN Allergan8.77%
BIIB Biogen6.15%
ILMN Illumina Inc5.49%
INCY Incyte Corp5.19%
VRTX Vertex Pharmaceuticals Inc4.76%
BMRN Biomarin Pharmaceutical Inc4.60%
ALXN Alexion Pharmaceuticals Inc4.24%

Search for Jobs